Selected Grants
COMBINE - ARLG 2.0 - DEPRU Site Budget (Yr8 of ARLG/Yr1 of ARLG 2.0)
Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Nipocalimab Administered to Adults with Generalized
A Long-Term, Single-Arm, Open-label, Multicenter Phase 3 Study to Evaluate the Safety
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program